The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature
Dec. 14, 2020 • ~7 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus immunology
Scientists have used gene therapy to regenerate damaged nerve fibres in the eye, in a discovery that could aid the development of new treatments for glaucoma,
Nov. 5, 2020 • ~5 min
spotlight-on-neuroscience spotlight-on-future-therapeutics neuroscience eyesight eye glaucoma
Gold nanotubes – tiny hollow cylinders one thousandth the width of a human hair – could be used to treat mesothelioma, a type of cancer caused by exposure to
Oct. 27, 2020 • ~4 min
advanced-materials spotlight-on-future-therapeutics cancer
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as late autumn, thanks to a £1.9million award from
Aug. 26, 2020 • ~7 min
spotlight-on-future-therapeutics infectious-diseases covid-19 coronavirus vaccine
Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.
June 11, 2020 • ~3 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases covid-19 coronavirus
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.
May 7, 2020 • ~6 min
spotlight-on-future-therapeutics medicine future-therapeutics covid-19 coronavirus
The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.
March 16, 2020 • ~5 min
spotlight-on-future-therapeutics future-therapeutics type-1-diabetes diabetes app
The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.
March 13, 2020 • ~6 min
spotlight-on-future-therapeutics future-therapeutics infectious-diseases
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.
Dec. 2, 2019 • ~7 min
spotlight-on-future-therapeutics future-therapeutics diagnostic protein proteomics
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.
June 24, 2019 • ~5 min